DOMINIQUE HUNT: Open Payments
NPI 1104201730 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 61 payments from 13 companies in 2025. Trend: 2023 $1,202 · 2024 $1,246 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $379 |
| Janssen Biotech, Inc. | 4 | $92 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Arcutis Biotherapeutics, Inc. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Amgen Inc. | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $31 |
| GENZYME CORPORATION | 1 | $28 |
| Almirall LLC | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: RINVOQ, SKYRIZI, TREMFYA, Sotyktu, DUPIXENT, Zoryve, OTEZLA, NEMLUVIO.
Industry payments across OH — which companies pay providers there.
